Kanda Shoichi | Cardiovascular-metabolics Research Laboratories R&d Division Daiichi Sankyo Co. Ltd.
スポンサーリンク
概要
- KANDA Shoichiの詳細を見る
- 同名の論文著者
- Cardiovascular-metabolics Research Laboratories R&d Division Daiichi Sankyo Co. Ltd.の論文著者
Cardiovascular-metabolics Research Laboratories R&d Division Daiichi Sankyo Co. Ltd. | 論文
- Contributions of Hepatic Gluconeogenesis Suppression and Compensative Glycogenolysis on the Glucose-Lowering Effect of CS-917, a Fructose 1,6-Bisphosphatase Inhibitor, in Non-obese Type 2 Diabetes Goto-Kakizaki Rats
- Contributions of Hepatic Gluconeogenesis Suppression and Compensative Glycogenolysis on the Glucose-Lowering Effect of CS-917, a Fructose 1,6-Bisphosphatase Inhibitor, in Non-obese Type 2 Diabetes Goto-Kakizaki Rats
- Potent Antidiabetic Effects of Rivoglitazone, a Novel Peroxisome Proliferator-Activated Receptor-γ Agonist, in Obese Diabetic Rodent Models